Cite

HARVARD Citation

    Johansson, S. et al. (2018). A clinical follow‐up of omalizumab in routine treatment of allergic asthma monitored by CD‐sens. Immunity, inflammation and disease. 6 (3), pp. 382-391. [Online]. 
  
Back to record